Seres Therapeutics
MCRB
#8894
Rank
NZ$0.25 B
Marketcap
NZ$28.01
Share price
0.69%
Change (1 day)
2.44%
Change (1 year)

Market capitalization of Seres Therapeutics (MCRB)

Market cap: NZ$0.25 Billion

As of January 2026 Seres Therapeutics has a market cap of NZ$0.25 Billion. This makes Seres Therapeutics the world's 8894th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Seres Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.25 B10.73%
2025NZ$0.22 B-10.23%
2024NZ$0.25 B-10.91%
2023NZ$0.28 B-73.96%
2022NZ$1.09 B-1.94%
2021NZ$1.12 B-63.91%
2020NZ$3.10 B764.27%
2019NZ$0.35 B30.26%
2018NZ$0.27 B-52.33%
2017NZ$0.57 B0.33%
2016NZ$0.57 B-71.22%
2015NZ$2.00 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Seres Therapeutics was reported to be:

NZ$0.25 Billion
by Nasdaq info icon info icon
NZ$0.25 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Xencor
XNCR
NZ$1.79 B 609.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$19.04 B 7,414.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Agios Pharmaceuticals
AGIO
NZ$2.91 B 1,051.70%๐Ÿ‡บ๐Ÿ‡ธ USA